CIK 0001726445
- Non-accelerated filer
- Smaller reporting company
Seer, Inc.
Sign in to watch- Ticker
- SEER
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 821153150
- Phone
- +1 650-453-0000
- Business address
- 3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY, CA, 94065
- Former names
- Seer Biosciences, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,578
- in 1 filing
Net −$3,578. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-17 | Farokhzad Omid CEO and Chair of the Board | Conversion | +135,611 | 135,611 | ||
| 2021-02-17 | Farokhzad Omid CEO and Chair of the Board | Sale | −135,611 | $64.15 | $8.7M | 0 |
| 2021-02-17 | Farokhzad Omid CEO and Chair of the Board | Conversion · Class B Common Stock | −219,130 | 1,303,478 | ||
| 2021-02-17 | Farokhzad Omid CEO and Chair of the Board | Conversion · Class B Common Stock | −135,611 | 2,251,717 | ||
| 2021-02-16 | Ronaghi Mostafa Director | Grant or award · Stock Option (right to buy) | +27,939 | 27,939 | ||
| 2021-02-01 | OSTADAN OMEAD President & COO | Grant or award | +41,250 | 377,448 | ||
| 2021-02-01 | OSTADAN OMEAD President & COO | Grant or award · Employee Stock Option (right to buy) | +41,250 | 41,250 | ||
| 2021-02-01 | Horn David R. Chief Financial Officer | Grant or award | +34,125 | 230,966 | ||
| 2021-02-01 | Horn David R. Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +34,125 | 34,125 | ||
| 2021-02-01 | Farokhzad Omid CEO and Chair of the Board | Conversion | +359,501 | 645,116 | ||
| 2021-02-01 | Farokhzad Omid CEO and Chair of the Board | Conversion | +416,409 | 416,409 | ||
| 2021-02-01 | Farokhzad Omid CEO and Chair of the Board | Sale | −313,369 | $64.15 | $20.1M | 297,487 |
| 2021-02-01 | Farokhzad Omid CEO and Chair of the Board | Sale | −359,501 | $64.15 | $23.1M | 285,615 |
| 2021-02-01 | Farokhzad Omid CEO and Chair of the Board | Sale | −416,409 | $64.15 | $26.7M | 0 |
| 2021-02-01 | Farokhzad Omid CEO and Chair of the Board | Grant or award | +87,000 | 384,487 | ||
| 2021-02-01 | Farokhzad Omid CEO and Chair of the Board | Conversion · Class B Common Stock | −359,501 | 1,522,608 | ||
| 2021-02-01 | Farokhzad Omid CEO and Chair of the Board | Conversion · Class B Common Stock | −416,409 | 2,387,328 | ||
| 2021-02-01 | Farokhzad Omid CEO and Chair of the Board | Grant or award · Employee Stock Option (right to buy) | +87,000 | 87,000 | ||
| 2021-02-01 | Invus Public Equities, L.P. 10% owner | Sale | −252,545 | $64.15 | $16.2M | 5,588,366 |
| 2021-01-27 | Farokhzad Omid CEO and Chair of the Board | Exercise or conversion | +309,313 | $0.04 | $13K | 588,536 |
Page 13 of 17 · 337 trades